AVRW — Avenir Wellness Solutions Income Statement
0.000.00%
- $0.01m
- $8.86m
- $4.35m
Annual income statement for Avenir Wellness Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.376 | 1.82 | 6.5 | 4.9 | 4.35 |
| Cost of Revenue | |||||
| Gross Profit | 0.145 | 0.743 | 4.33 | 3.34 | 3.11 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 17.6 | 20.8 | 20.9 | 23.1 | 8.72 |
| Operating Profit | -17.3 | -19 | -14.4 | -18.2 | -4.37 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -21.4 | -30.6 | -13.2 | -18.5 | -3.44 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -21.4 | -30.6 | -13.2 | -18.5 | -3.44 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -21.4 | -30.6 | -13.2 | -25.5 | -3.44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21.4 | -30.6 | -13.2 | -25.5 | -3.44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.522 | -0.652 | -0.278 | -0.168 | -0.058 |